These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7516019)

  • 1. Relationships between acute and chronic beta-blocking effects of bisoprolol in healthy volunteers: a practical approach to predict intensity of beta-blockade.
    Jamin P; LeCoz F; Funck-Brentano C; Poirier JM; Jaillon P
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):658-63. PubMed ID: 7516019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of nadolol and bisoprolol on the isoprenaline-evoked dilatation of the dorsal hand vein in man.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 2001 Jun; 51(6):583-9. PubMed ID: 11422018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.
    Stoschitzky K; Stoschitzky G; Brussee H; Bonelli C; Dobnig H
    Cardiology; 2006; 106(4):199-206. PubMed ID: 16679760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bisoprolol and atenolol on endurance exercise capacity in healthy men.
    Vanhees L; Defoor JG; Schepers D; Lijnen P; Peeters BY; Lacante PH; Fagard RH
    J Hypertens; 2000 Jan; 18(1):35-43. PubMed ID: 10678541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A metabolic assessment of the beta 1 selectivity of bisoprolol.
    Haffner CA; Horton RC; Lewis HM; Hughes B; Kendall MJ
    J Hum Hypertens; 1992 Oct; 6(5):397-400. PubMed ID: 1361206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral pharmacokinetics of bisoprolol in resting and exercising healthy volunteers.
    Le Coz F; Sauleman P; Poirier JM; Cuche JL; Midavaine M; Rames A; Lecocq B; Jaillon P
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):28-34. PubMed ID: 1719288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy.
    Wellstein A; Palm D; Belz GG; Butzer R; Polsak R; Pett B
    Eur Heart J; 1987 Dec; 8 Suppl M():3-8. PubMed ID: 2897299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisoprolol, a once-a-day beta-blocking agent for patients with mild to moderate hypertension.
    Davidov ME; Singh SP; Vlachakis ND; Blumenthal JB; Simon JS; Bryzinski BS; Koury KJ; Alemayehu D
    Clin Cardiol; 1994 May; 17(5):263-8. PubMed ID: 8004841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of oral beta blockade on cardiovascular and sympathetic regulation.
    Beloka SP; Gouveia S; Gujic M; Naeije R; Rocha AP; van de Borne P
    J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):323-31. PubMed ID: 19903982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of beta(1)-selective adrenergic blockade on maximal blood lactate steady state in healthy men.
    Wonisch M; Hofmann P; Fruhwald FM; Hoedl R; Schwaberger G; Pokan R; von Duvillard SP; Klein W
    Eur J Appl Physiol; 2002 May; 87(1):66-71. PubMed ID: 12012078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
    Chang PC; van Veen S; van der Krogt JA; Vermeij P; van Brummelen P
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):317-22. PubMed ID: 2464104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive inotropic effects of the beta 2-adrenoceptor agonist terbutaline in the human heart: effects of long-term beta 1-adrenoceptor antagonist treatment.
    Schäfers RF; Adler S; Daul A; Zeitler G; Vogelsang M; Zerkowski HR; Brodde OE
    J Am Coll Cardiol; 1994 Apr; 23(5):1224-33. PubMed ID: 8144793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pretreatment with the selective beta 1-adrenoceptor antagonist bisoprolol on the subsequent cardiovascular actions and beta-adrenoceptor subtype specific occupancy of celiprolol in healthy man.
    de Mey C; Beithaupt K; Palm D; Fuhr U; Belz GG
    Eur J Clin Pharmacol; 1993; 44(4):341-8. PubMed ID: 8390369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of bisoprolol on respiratory sinus arrhythmia.
    Wargon M; Laude D; Girard A; Elghozi JL
    Fundam Clin Pharmacol; 1998; 12(4):451-6. PubMed ID: 9711469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bisoprolol with other beta-adrenoceptor blocking drugs.
    Krämer B; Balser J; Stubbig K; Krämer G; Kübler W
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S46-57. PubMed ID: 2439798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE; Cragg DJ; Bacon RJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
    Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
    Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of nadolol and bisoprolol on noradrenaline-evoked venoconstriction in man in vivo.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 1998 Mar; 45(3):271-6. PubMed ID: 9517371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of different bisoprolol doses on hemodynamics, plasma catecholamines, platelet aggregation, and alpha 2- and beta-receptors in hypertensive patients.
    Kirsten R; Neff J; Heintz B; Nemeth N; Rahlfs VW; Nelson K
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S113-21. PubMed ID: 2439781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.